Filing Details
- Accession Number:
- 0000903423-18-000616
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-19 19:22:22
- Reporting Period:
- 2018-11-16
- Accepted Time:
- 2018-11-19 19:22:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1578845 | Allergan Plc | AGN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1269428 | M Matthew Walsh | Clonshaugh Business And Technology Park Dublin L2 D17 E400 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, Par Value $0.0001 | Acquisiton | 2018-11-16 | 1,000 | $157.00 | 26,416 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes restricted shares issued pursuant to the Amended and Restated Allergan, Inc. 2011 Incentive Award Plan.
Billionaire Hedge Funds
